Terms: = Liver cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Treatment
12 results:
1. Design, synthesis and biological evaluation of indazole derivatives as selective covalent inhibitors of FGFR4 in wild-type and gatekeeper mutants.
Yang Y; He X; Li Z; Ran K; Wang N; Zhao L; Liu Z; Zeng J; Chang B; Feng Q; Zhang Q; Yu L
Eur J Med Chem; 2023 Oct; 258():115628. PubMed ID: 37437349
[TBL] [Abstract] [Full Text] [Related]
2. Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation.
Waraky A; Östlund A; Nilsson T; Weichenhan D; Lutsik P; Bähr M; Hey J; Tunali G; Adamsson J; Jacobsson S; Morsy MHA; Li S; Fogelstrand L; Plass C; Palmqvist L
Haematologica; 2024 Mar; 109(3):725-739. PubMed ID: 37317878
[TBL] [Abstract] [Full Text] [Related]
3. A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of 2-Amino-7-sulfonyl-7
Xie W; Yang S; Liang L; Wang M; Zuo W; Lei Y; Zhang Y; Tang W; Lu T; Chen Y; Jiang Y
J Med Chem; 2022 Dec; 65(24):16570-16588. PubMed ID: 36480917
[TBL] [Abstract] [Full Text] [Related]
5. Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation.
Nam Y; Shin I; Kim Y; Ryu S; Kim N; Ju E; Sim T
Neoplasia; 2022 Jan; 24(1):34-49. PubMed ID: 34864570
[TBL] [Abstract] [Full Text] [Related]
6. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
[TBL] [Abstract] [Full Text] [Related]
7. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
[TBL] [Abstract] [Full Text] [Related]
8. Myeloid neoplasm with the abnormality of PDGFRB gene secondary interstitial pneumonia: A case report.
Liu G; Ouyang R; Chen P; Liu T; Zhou L; Shen C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):345-348. PubMed ID: 32386029
[TBL] [Abstract] [Full Text] [Related]
9. A novel etv6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
[TBL] [Abstract] [Full Text] [Related]
10. telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity.
Saber S; Khodir AE; Soliman WE; Salama MM; Abdo WS; Elsaeed B; Nader K; Abdelnasser A; Megahed N; Basuony M; Shawky A; Mahmoud M; Medhat R; Eldin AS
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1591-1604. PubMed ID: 31367864
[TBL] [Abstract] [Full Text] [Related]
11. Simultaneous occurrence of etv6-RUNX1 and BCR-abl1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
[TBL] [Abstract] [Full Text] [Related]
12. [Non-Hodgkin's lymphoma in an elderly patient complicated by cyclophosphamide-induced allergic hepatic dysfunction].
Arai N; Kaneko H; Umeda M; Tsukahara T; Shirai T
Nihon Ronen Igakkai Zasshi; 1992 Sep; 29(9):681-5. PubMed ID: 1434065
[TBL] [Abstract] [Full Text] [Related]